However, the Medicines and Healthcare products Regulatory Agency (MHRA) has warned that asthma sufferers should not rely on ...

Biogen’s Skyclarys (omaveloxolone) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the ...

People with asthma are being warned they are at increased risk of severe asthma attacks if they just rely on blue inhalers.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Skyclarys (omaveloxolone), the first treatment ...

As with all products, we will keep its safety under close review. The Medicines and Healthcare products Regulatory Agency ...

An urgent warning has been issued to asthma sufferers over the use of a vital treatment to relieve their symptoms. There are ...

Lercanidipine HCl 20mg Tablets, a drug that is consumed by adults for hypertension, was recalled by the UK's MHRA over the ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

Pfizer’s Hympavzi (marstacimab) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 ...

The AERIAL trial will assess LEU011, which has MHRA Innovation Passport status, for solid tumors, a challenging area compared ...

Short Summary The EU, UK, and USA each have distinct and evolving regulatory systems for medicines and medical devices, involving strict approval, surveillance, and market access requirements managed ...